Insulet Introduces a New Hero, Powered by Omnipod, to Inspire and Empower the Diabetes Community Through Representation, in Collaboration with Marvel Comics

New comic in collaboration with Marvel Comics, celebrates authentic diabetes representation and empowers people living with diabetes to see themselves as heroes of their own stories.

ACTON, Mass. - (November 10, 2026) - Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod^® brand of products, today announced the launch of a new comic, Gluconaut: Strength of Stars, developed in collaboration with Marvel Comics. The latest comic features Podrick, a high school student who is navigating life with type 1 diabetes and worries about fitting in. When he embraces Omnipod, he gains confidence in managing his diabetes and transforms into the hero, Gluconaut.

This new comic continues Insulet's mission to inspire people with diabetes and empower them to adopt diabetes technology for the potential of improved results and quality of life.

Through Podrick's relatable story, readers can see themselves reflected in a hero who realizes that when he feels his best, his confidence and self-acceptance improve. The new character, Gluconaut, builds on the momentum of the first collaboration with Marvel featuring Dyasonic. The debut of Dyasonic demonstrated the power of meaningful representation in pop culture, showcasing strength and resilience while helping establish a new generation of diabetes heroes. This current comic explores how confidence, self-acceptance and supportive technology can help people with diabetes live fully and authentically.

"Our commitment to the diabetes community goes beyond innovation alone," said Ashley McEvoy, Insulet President and Chief Executive Officer. "While technologies such as Omnipod 5 help simplify life with diabetes, one in three people with type 1 diabetes in the U.S. say they have hidden their condition. That's a reminder that representation matters. We continue our work with Marvel because stories can shape beliefs and spark understanding in ways facts alone cannot. Our new hero, Gluconaut, builds on the impact of Dyasonic, helping young people with diabetes see themselves as empowered by what's possible and not limited by their condition."

According to a U.S. survey conducted by Insulet, diabetes representation remains critically important to the community. The majority of people living with type 1 diabetes (51%) surveyed indicated the importance of seeing their condition accurately represented in culture and media. However, many (37%) reported rarely or never (14%) seeing such representation. When people see themselves reflected in mainstream culture, it reinforces that their experiences, challenges and victories are important. By bringing type 1 diabetes to the forefront, this collaboration demonstrates that diabetes doesn't have to be a limitation; it's part of a much bigger story.

Stigma remains a major challenge for people with type 1 diabetes, making authentic representation essential to reducing self-consciousness and fear of judgment while fostering greater understanding and acceptance. Written by Pallie Paul Allor, who lives with diabetes, Gluconaut: Strength of Stars explores the critical issue of stigma through Podrick's journey. Allor's perspective helps bring authenticity to the story while encouraging readers to embrace their own journeys with confidence.

To further extend the impact of the campaign beyond the page, Insulet has partnered with Children with Diabetes (CWD), a non-profit organization dedicated to providing education and support to families living with type 1 diabetes. Community members and supporters can participate by sharing Gluconaut GIFs on social media, while Insulet will provide scholarships enabling families to attend CWD's Friends for Life Orlando conferences, where peers connect, learn, and feel truly seen.

"Stories have the power to shape how we see ourselves and how others understand our experiences," said Jeff Hitchcock, Founder, President, and CEO of Children with Diabetes. "For young people living with diabetes, authentic representation sends a powerful message: you are not alone, and your story matters. Through Gluconaut and our partnership with Insulet, we're helping create opportunities for connection, confidence and hope. That's transformative work for our community."

To access Gluconaut: Strength of Stars and explore related materials, visit Omnipod.com/marvel.

¹ The national survey results are based upon the responses of 1,015 U.S. adults living with type 1 diabetes. Thrivable conducted an online survey on behalf of Insulet between Oct. 13 and Oct. 20, 2021, using the Thrivable proprietary Health Panel Database.

About Insulet Corporation:

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet's flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, visit Insulet.com or omnipod.com.

©2026 Insulet Corporation. Omnipod is a registered trademark of Insulet Corporation. All rights reserved. All other trademarks are the property of their respective owners. The use of third party trademarks does not constitute an endorsement or imply a relationship of other affiliation.

About Children with Diabetes:

Children with Diabetes is an Ohio-based 501(c)(3) non-profit organization dedicated to providing education and support to families living with type 1 diabetes. Our official corporate name is T-1 Today, Inc. (Ohio Charter 2231845) with a Trade Name Filing for Children with Diabetes. Most people know us as Children with Diabetes.

Media:
Joan Campion
Vice President, External Communications
[email protected]

Investor Relations:
Clare Trachtman
Vice President, Investor Relations
[email protected]

Source: Insulet Corporation